RogCon

    OverviewSuggest Edit

    RogCon Biosciences is a biotechnology company. It is engaged in discovering and developing therapeutics for children suffering from SCN2A mutations, that cause epilepsy, autism, and other neurological disorders.

    TypePrivate
    Founded2015
    Websiterogcon.com

    Latest Updates

    Employees (est.) (Feb 2021)4
    Cybersecurity ratingAMore

    RogCon Financials and Metrics

    Summary Metrics

    Founding Date

    2015

    RogCon Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    95/100

    SecurityScorecard logo

    RogCon Online and Social Media Presence

    Embed Graph

    RogCon Frequently Asked Questions

    • When was RogCon founded?

      RogCon was founded in 2015.

    • How many employees does RogCon have?

      RogCon has 4 employees.

    • Who are RogCon competitors?

      Competitors of RogCon include ImCheck Therapeutics, Atara Biotherapeutics and Seneca Biopharma.